Showing results (251-260 of 315) with videos related to
Sort By:
Pageof 32
Endoscopy|February 13, 2015
Computed tomographic enterography adds value to colonoscopy in differentiating Crohn's disease from intestinal tuberculosis: a potential diagnostic algorithmRen Mao, Wang-di Liao, Yao He, et al.Phytotherapy Research : PTR|December 19, 2023
International clinical practice guideline on the use of traditional Chinese medicine for ulcerative colitis by Board of Specialty Committee of Digestive System Disease of World Federation of Chinese Medicine Societies (2023)Shengsheng Zhang, Luqing Zhao, Hong Shen, et al.Journal of Gastroenterology and Hepatology|February 26, 2013
Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based studyZhirong Zeng, Zhenhua Zhu, Yuyu Yang, et al.Intestinal Research|May 14, 2016
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's diseaseKai-Chun Wu, Zhi Hua Ran, Xiang Gao, et al.BMC Medicine|May 11, 2023
Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn's disease: a multi-omics Mendelian randomization studyShu Xu, Xiaozhi Li, Shenghong Zhang, et al.Stem Cell Research & Therapy|January 23, 2019
Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cellsKang Chao, Shenghong Zhang, Yun Qiu, et al.The American Journal of Gastroenterology|February 12, 2019
Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter StudyYao He, Zhenhua Zhu, Yujun Chen, et al.Stem Cell Research & Therapy|August 13, 2016
Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cellsKang Chao, Shenghong Zhang, Yun Qiu, et al.Helicobacter|October 17, 2012
Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trialJie Liang, Jun Li, Ying Han, et al.Journal of Gastroenterology and Hepatology|September 13, 2018
The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndromeYinglian Xiao, Yuwen Li, Jianchang Shu, et al.Pageof 32